ABIVAX SA         EO -,01
ABIVAX SA EO -,01
Share · FR0012333284 · A14UQC (XPAR)
Overview Financial Indicators
6,34 EUR
-6,63 % -0,45 EUR
Paris · Current prices and charts at MoneyPeak
11.06.2025 18:38

Current Prices from ABIVAX SA EO -,01

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
0RA9.L
EUR
11.06.2025 13:09
6,64 EUR
6,79 EUR
-2,21 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -7,19 % 7,07 % 6,35 % -20,77 % -37,12 % -37,12 %

Company Profile for ABIVAX SA EO -,01 Share

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.

Company Data

Name ABIVAX SA EO -,01
Company ABIVAX SA
Website https://www.abivax.com
Primary Exchange XPAR Paris
WKN A14UQC
ISIN FR0012333284
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mr. Marc M. P. de Garidel M.B.A.
Market Capitalization 327 Mio
Country France
Currency EUR
Employees 0,1 T
Address 5, rue de la Baume, 75008 Paris
IPO Date 2016-09-30

Ticker Symbols

Name Symbol
Frankfurt 2X1.F
London 0RA9.L

More Shares

Investors who ABIVAX SA EO -,01 hold also have the following shares in their portfolio:
Fidelity Sustainable Global Corporate Bond Multifactor UCITS ETF
Fidelity Sustainable Global Corporate Bond Multifactor UCITS ETF ETF
TRAFFORD CENTRE FINANCE LD 'D2' 8.28% SEC NTS 28/10/22 £ (BR)
TRAFFORD CENTRE FINANCE LD 'D2' 8.28% SEC NTS 28/10/22 £ (BR) Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025